Video Library

Strategies astronauts use to stay fit during space flight can help bone marrow/stem cell transplant and CAR T-cell recipients.

Late effects after an allogeneic transplant (a transplant using donor cells) can affect the physical, psychological, and social well-being of survivors. Dr. Hamilton sheds light on the most common long-term effects and how they can best be managed to minimize complications. She also stresses the importance of ongoing survivorship care to ensure that survivors can live life to the fullest.

In the years after having a transplant using your own cells (autologous transplant), complications can develop. This presentation describes possible late complications, risk factors for each complication, ways that you can help minimize the risks, and strategies for managing any complications that do occur.

CAR T-cell therapy is an exciting second-line option for patients living with relapsed multiple myeloma. In this presentation, Dr. Ahmed reviews each step in the CAR T process and discusses a number of studies that support its use. Potential side effects are reviewed, and exciting future trends are discussed.

La terapia de Células CAR-T es una nueva terapia para pacientes con mieloma múltiple. Esta presentación explica qué es la terapia de Células CAR-T, cuál es su eficacia para los pacientes con mieloma y los posibles efectos secundarios.

CAR T therapy (chimeric antigen receptor therapy) is a new treatment strategy that has been shown to improve patient outcomes. In this lecture, Dr. William reviews the steps involved, including T-cell collection, lymphodepleting chemotherapy, reinfusion of T-cells, and follow-up care. Potential side effects and their treatments are discussed as wel

La terapia de células CAR T es un tratamiento nuevo para pacientes que tienen ciertos tipos de linfoma no Hodgkin. Conozca lo que implica someterse a una terapia de células CAR T, quién es un buen candidato y los posibles resultados.

Advanced age has traditionally been seen as prohibitive for treatments like stem cell transplants and CAR T therapy. This presentation reviews evidence that overall fitness is a crucial factor in reducing non-relapse mortality and that otherwise healthy elderly patients can have successful outcomes after transplant and CAR T-cell therapy.

Multiple studies have shown that most patients who receive chimeric antigen receptor (CAR) T-cell therapy report a good quality of life long-term. Learn how CAR T-cell therapy is performed and its short-term and long-term effects on patients and caregivers. Discover key differences between CAR T-cell, stem cell transplant and other and chemotherapy treatments.

The microbiome plays a crucial role in our overall health and our response to cancer treatment. In her lecture, Dr. Shah discusses studies that highlight the significance of dietary diversity and a high-fiber diet. She also offers advice on how to implement these changes before, during, and after cancer treatment.

What you eat can significantly impact recovery after transplant and CAR T-cell therapy. This presentation discusses the nutritional needs of stem cell transplant and CAR T-cell recipients in the short- and long-term; how food choices affect organ function and help prevent complications; how to manage eating difficulties; the role of prebiotics and probiotic in nutrition; and common myths about the relationship between cancer and nutrition.

Caregivers are critical to the United States (US) Health Care system as more procedures are moved outpatient and home care is required. Yet they must deal with the emotional toll of the responsibilities, the financial impact of being a caregiver and the accompanying negative emotions. Often times, caregivers are required to perform tasks previously performed by medical professionals yet caregivers don’t necessarily have the training. Just like the cancer patients, caregivers experience a whole range of negative emotions which need to be acknowledged and addressed.